A business in context

RVMD research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-10-23 · 8022 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 8-K · Current report

    Report date 2026-10-08 · 0001628171-26-000004 · Items 2.03,8.01

  2. 4 · Ownership change

    Report date 2026-09-29 · 0001835966-26-000008

  3. 4 · Ownership change

    Report date 2026-09-25 · 0001969082-26-000011

  4. 4 · Ownership change

    Report date 2026-09-24 · 0002124509-26-000012

  5. 4 · Ownership change

    Report date 2026-09-22 · 0001758247-26-000004

  6. 4 · Ownership change

    Report date 2026-09-18 · 0002124509-26-000010

  7. 4 · Ownership change

    Report date 2026-09-16 · 0002124509-26-000008

  8. 4 · Ownership change

    Report date 2026-09-16 · 0001969082-26-000009

  9. 4 · Ownership change

    Report date 2026-09-16 · 0001835966-26-000006

  10. 8-K · Current report

    Report date 2026-08-27 · 0001193125-26-377362 · Items 1.01,2.03

  11. 8-K · Current report

    Report date 2026-08-26 · 0001193125-26-366931 · Items 8.01

  12. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001193125-26-335104

  13. 8-K · Current report

    Report date 2026-08-05 · 0001193125-26-335039 · Items 2.02,9.01

  14. 8-K · Current report

    Report date 2026-06-18 · 0001193125-26-276718 · Items 5.02,5.07

  15. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001193125-26-208969

  16. 8-K · Current report

    Report date 2026-05-06 · 0001193125-26-208918 · Items 2.02,9.01

  17. DEF 14A · Proxy statement

    Report date 2026-06-18 · 0001193125-26-182453

  18. 8-K · Current report

    Report date 2026-04-14 · 0001193125-26-161800 · Items 1.01,2.03,8.01,9.01

  19. 8-K · Current report

    Report date 2026-04-14 · 0001193125-26-159289 · Items 8.01,9.01

  20. 8-K · Current report

    Report date 2026-04-13 · 0001193125-26-152039 · Items 8.01

  21. 10-K · Annual report

    Report date 2025-12-31 · 0001193125-26-071563

  22. 8-K · Current report

    Report date 2026-02-25 · 0001193125-26-071517 · Items 2.02,9.01

  23. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001193125-25-266923

  24. 8-K · Current report

    Report date 2025-11-05 · 0001193125-25-266836 · Items 2.02,9.01

  25. 8-K · Current report

    Report date 2025-10-16 · 0001193125-25-241736 · Items 8.01

  26. 8-K · Current report

    Report date 2025-09-10 · 0001193125-25-200078 · Items 8.01

  27. 10-Q · Quarterly report

    Report date 2025-06-30 · 0000950170-25-104022

  28. 8-K · Current report

    Report date 2025-08-06 · 0000950170-25-103983 · Items 2.02,9.01

  29. 8-K · Current report

    Report date 2025-06-26 · 0001193125-25-151254 · Items 5.07

  30. 8-K · Current report

    Report date 2025-06-23 · 0001193125-25-145242 · Items 1.01,2.03,7.01,9.01

  31. 8-K · Current report

    Report date 2025-06-18 · 0001193125-25-142735 · Items 5.02

  32. 10-Q · Quarterly report

    Report date 2025-03-31 · 0000950170-25-065660

  33. 8-K · Current report

    Report date 2025-05-07 · 0000950170-25-065618 · Items 2.02,9.01

  34. DEF 14A · Proxy statement

    Report date 2025-06-26 · 0001193125-25-103947

  35. 10-K · Annual report

    Report date 2024-12-31 · 0000950170-25-027736

  36. 8-K · Current report

    Report date 2025-02-26 · 0000950170-25-027707 · Items 2.02,9.01

  37. 8-K · Current report

    Report date 2024-12-03 · 0001193125-24-271540 · Items 8.01,9.01

  38. 8-K · Current report

    Report date 2024-12-02 · 0001193125-24-268404 · Items 8.01

  39. SC 13G/A · Ownership disclosure

    0000902219-24-000477

  40. 10-Q · Quarterly report

    Report date 2024-09-30 · 0000950170-24-122303

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-10-23 · 2026 Q3: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 83 transaction rows83SGrant / award: 0 transaction rows0AExercise / conversion: 18 transaction rows18MTax / exercise payment: 0 transaction rows0FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

101 matching transaction rows. Showing 1 to 50.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-09-25
2026-09-28
Mancini AnthonyS · Sale
Disposed
Common Stock3121.0200.54
2026-09-25
2026-09-28
Mancini AnthonyM · Exercise / conversion
Acquired
Common Stock3121.033.62
2026-09-25
2026-09-28
Mancini AnthonyM · Exercise / conversion
Disposed
Stock Option (Right to Buy)
Derivative security
3121.00.0
2026-09-25
2026-09-29
Cislini JeffS · Sale
Disposed
Common Stock765.0207.32
2026-09-24
2026-09-28
Mancini AnthonyS · Sale
Disposed
Common Stock587.0200.0
2026-09-22
2026-09-24
ANDERSON ELIZABETH MS · Sale
Disposed
Common Stock100.0195.15
2026-09-22
2026-09-24
ANDERSON ELIZABETH MS · Sale
Disposed
Common Stock2648.0193.44
2026-09-22
2026-09-24
ANDERSON ELIZABETH MS · Sale
Disposed
Common Stock4985.0192.54
2026-09-22
2026-09-24
ANDERSON ELIZABETH MS · Sale
Disposed
Common Stock910.0191.85
2026-09-22
2026-09-24
ANDERSON ELIZABETH MM · Exercise / conversion
Acquired
Common Stock5070.01.12
2026-09-22
2026-09-24
ANDERSON ELIZABETH MS · Sale
Disposed
Common Stock1500.0194.59
2026-09-22
2026-09-24
ANDERSON ELIZABETH MM · Exercise / conversion
Disposed
Stock Option (Right to Buy)
Derivative security
5070.00.0
2026-09-18
2026-09-22
Mancini AnthonyS · Sale
Disposed
Common Stock1764.0196.94
2026-09-16
2026-09-18
Mancini AnthonyS · Sale
Disposed
Common Stock1747.0199.3
2026-09-16
2026-09-18
Mancini AnthonyS · Sale
Disposed
Common Stock27.0195.05
2026-09-16
2026-09-18
Cislini JeffS · Sale
Disposed
Common Stock52.0195.01
2026-09-16
2026-09-18
Cislini JeffS · Sale
Disposed
Common Stock3314.0199.3
2026-09-16
2026-09-18
Sandler Alan B.S · Sale
Disposed
Common Stock336.0199.3
2026-09-16
2026-09-18
Sandler Alan B.S · Sale
Disposed
Common Stock5.0194.96
2026-09-16
2026-09-18
Anders JackS · Sale
Disposed
Common Stock3992.0199.3
2026-09-16
2026-09-18
Anders JackS · Sale
Disposed
Common Stock61.0195.0
2026-09-16
2026-09-18
Kelsey Stephen MichaelS · Sale
Disposed
Common Stock85.0195.01
2026-09-16
2026-09-18
Kelsey Stephen MichaelS · Sale
Disposed
Common Stock5484.0199.3
2026-09-16
2026-09-18
Horn Margaret AS · Sale
Disposed
Common Stock4891.0199.3
2026-09-16
2026-09-18
Horn Margaret AS · Sale
Disposed
Common Stock76.0195.01
2026-09-16
2026-09-18
GOLDSMITH MARK AS · Sale
Disposed
Common Stock213.0195.01
2026-09-16
2026-09-18
GOLDSMITH MARK AS · Sale
Disposed
Common Stock13775.0199.3
2026-09-11
2026-09-15
Kelsey Stephen MichaelS · Sale
Disposed
Common Stock3270.0205.81
2026-09-11
2026-09-15
Kelsey Stephen MichaelS · Sale
Disposed
Common Stock4995.0204.84
2026-09-11
2026-09-15
Kelsey Stephen MichaelS · Sale
Disposed
Common Stock17949.0203.87
2026-09-11
2026-09-15
Kelsey Stephen MichaelS · Sale
Disposed
Common Stock18869.0203.06
2026-09-11
2026-09-15
Kelsey Stephen MichaelS · Sale
Disposed
Common Stock21447.0201.75
2026-09-11
2026-09-15
Kelsey Stephen MichaelS · Sale
Disposed
Common Stock13368.0200.78
2026-09-11
2026-09-15
Kelsey Stephen MichaelS · Sale
Disposed
Common Stock11833.0200.11
2026-09-11
2026-09-15
Kelsey Stephen MichaelS · Sale
Disposed
Common Stock800.0198.55
2026-09-11
2026-09-15
Kelsey Stephen MichaelM · Exercise / conversion
Acquired
Common Stock52500.042.45
2026-09-11
2026-09-15
Kelsey Stephen MichaelM · Exercise / conversion
Acquired
Common Stock40031.040.74
2026-09-11
2026-09-15
Kelsey Stephen MichaelM · Exercise / conversion
Disposed
Stock Option (Right to Buy)
Derivative security
40031.040.74
2026-09-11
2026-09-15
Kelsey Stephen MichaelM · Exercise / conversion
Disposed
Stock Option (Right to Buy)
Derivative security
52500.042.45
2026-09-10
2026-09-14
Mancini AnthonyS · Sale
Disposed
Common Stock2420.0205.05
2026-09-10
2026-09-14
Mancini AnthonyS · Sale
Disposed
Common Stock1179.0206.1
2026-09-10
2026-09-14
Mancini AnthonyS · Sale
Disposed
Common Stock300.0207.17
2026-09-10
2026-09-14
Mancini AnthonyS · Sale
Disposed
Common Stock6019.0203.28
2026-09-10
2026-09-14
Mancini AnthonyM · Exercise / conversion
Acquired
Common Stock9363.033.62
2026-09-10
2026-09-14
Mancini AnthonyS · Sale
Disposed
Common Stock5530.0204.14
2026-09-10
2026-09-14
Mancini AnthonyM · Exercise / conversion
Disposed
Stock Option (Right to Buy)
Derivative security
9363.00.0
2026-09-08
2026-09-10
Kim Lorence H.S · Sale
Disposed
Common Stock706.0206.6
2026-09-08
2026-09-10
Kim Lorence H.S · Sale
Disposed
Common Stock999.0207.33
2026-09-08
2026-09-10
Kim Lorence H.S · Sale
Disposed
Common Stock3587.0208.55
2026-09-08
2026-09-10
Kim Lorence H.S · Sale
Disposed
Common Stock371.0212.27

Identity & relationships

Wikidata structured data · retrieved 2026-10-23 · 1658 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001628171Revolution Medicines, Inc.

No parent relationship is available in this import; this is not proof of independence.

Legal Entity Identifier
549300JU3X0LBCQ65892
GLEIF legal name
REVOLUTION MEDICINES, INC.
Entity / LEI registration status
ACTIVE / LAPSED
Reference data updated
2026-08-12T14:58:24Z

direct-parent: no parent LEI supplied

ultimate-parent: no parent LEI supplied

GLEIF legal entity reference data · retrieved 2026-10-23 · 1197 checked identities; 0 unavailable records

Search names and former names

View Wikidata identity and references ↗

  • Revolution Medicines (United States) · alias · wikidata
Explore headquarters map ↗

Revenue in constant purchasing power

USD revenue expressed in 2026-09 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

Year endedReported USD revenueCPI-adjusted USD revenue
2024-12-31$0$0
2023-12-31$11.58M$12.80M
2022-12-31$35.38M$40.73M
2021-12-31$29.39M$36.54M
2020-12-31$42.98M$55.96M
2019-12-31$50.04M$65.95M
2018-12-31$20.16M$27.06M

Bureau of Labor Statistics · retrieved 2026-10-23 · 9 selected series; gaps remain missing

Explore the CPI history ↗